Table 3.
Incidence of all study-related adverse events by system organ class, by preferred term, and by grade (n = number of patients; total n=19)
| Grades | ||||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| Blood and lymphatic system disorders | ||||
| Anemia | 7 | 2 | 1 | |
| Neutropenia | 4 | 2 | ||
| Thrombocytopenia | 4 | 4 | 3 | 2 |
| Gastrointestinal | ||||
| Nausea | 1 | |||
| Increased aspartate aminotransferase | 1 | |||
| Hypoalbuminemia | 1 | 1 | ||
| Electrolyte imbalance | ||||
| Hypocalcemia | 4 | 3 | ||
| Hyperkalemia | 2 | |||
| Hypokalemia | 4 | |||
| Hypophosphatemia | 1 | 1 | ||
| Hypernatremia | 2 | |||
| Hyponatremia | 2 | |||
| Renal | ||||
| Renal failure (elevated Cr) | 2 | |||
| Hyperuricemia | 1 | |||
| Others | ||||
| Dyspnea | 1 | |||
| Febrile neutropenia | 1 | |||
| Sinus tachycardia | 1 | |||
| Peripheral neuropathy | 1 | |||